OrthoPediatrics Corp. (KIDS) Stock Forecast
KIDS analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 4.44 / 5 from 9 analysts
- Price target
- $27.22 average of analyst targets
- Upside to target
- +24.0% from the latest close
- Next earnings
- October 27, 2026 EPS estimate $-0.25
- 52-week range
- $14.64 – $26.50
KIDS analyst ratings
9 analystsNumber of analysts at each rating.
KIDS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
KIDS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.21 | −$0.25 | −$0.16 | −$0.24 | +10.4% | 6 |
| Current fiscal year (2026) | −$1.09 | −$1.14 | −$1.01 | −$1.00 | −9.2% | 4 |
| Next fiscal year (2027) | −$0.71 | −$0.92 | −$0.20 | −$1.09 | +35.0% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
KIDS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $68.5M | $68.1M | $68.8M | +11.8% | 9 |
| Current fiscal year (2026) | $267.0M | $265.9M | $267.8M | +13.0% | 9 |
| Next fiscal year (2027) | $298.8M | $295.0M | $303.0M | +11.9% | 9 |
KIDS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
KIDS revenue: reported and forecast
KIDS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.17 | −$0.17 | −$0.21 | −$0.21 | −$0.21 | +26.5% | 0 up · 3 down |
| Current fiscal year (2026) | −$1.05 | −$1.05 | −$1.09 | −$1.09 | −$1.09 | +3.9% | 1 up · 2 down |
| Next fiscal year (2027) | −$0.68 | −$0.68 | −$0.71 | −$0.71 | −$0.71 | +4.4% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
KIDS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; KIDS beat in 11 of 12.
What analysts expect from KIDS
9 analysts cover OrthoPediatrics; their consensus rating is buy (4.44 on a 1–5 scale, where 5 is a strong buy). The average price target is $27.22, 24.0% above the latest close of $21.95. Analysts expect earnings of −$1.09 per share for 2026, −9.2% from a year earlier. For 2027 the average estimate is −$0.71 per share on revenue of $298.8 million. OrthoPediatrics beat the EPS estimate in 11 of the last 12 quarters.
Related: KIDS income statement, KIDS key metrics, KIDS chart. See the KIDS stock overview for the latest quote and news.
KIDS forecast FAQ
What is OrthoPediatrics's price target?
The average analyst price target for OrthoPediatrics is $27.22, 24.0% above the latest close of $21.95.
Is OrthoPediatrics a buy, hold or sell?
Of 9 analysts covering OrthoPediatrics, 5 rate it a strong buy, 3 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is OrthoPediatrics's EPS forecast?
Analysts forecast −$1.09 per share for 2026 (range −$1.14 to −$1.01); for 2027 the estimate is −$0.71.
What is OrthoPediatrics's revenue forecast?
The average revenue estimate for 2026 is $267.0 million, growth of 13.0%; for 2027 it is $298.8 million.
When does OrthoPediatrics report earnings?
OrthoPediatrics is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 after the market closes; the EPS estimate is $-0.25.
Does OrthoPediatrics usually beat earnings estimates?
OrthoPediatrics reported EPS at or above the analyst estimate in 11 of the last 12 quarters.